Pilot Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: exemestane
Sponsor: Roxane Laboratories